Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Revolutionizing Protocol Generation

Revolutionizing Protocol Generation: How Agentic AI Drafts Compliant Plans in Minutes

Consider a cross-functional team huddled around spreadsheets, regulatory guidelines, and past trial data, spending weeks or sometimes months crafting a single clinical trial protocol; see protocol structure details. Every inclusion criterion, endpoint, and safety measure must align perfectly with ICH-GCP standards, FDA expectations, and real-world feasibility. One misalignment, and you risk costly amendments, delayed starts,…

Read More

AI for Patient-Reported Outcomes

How AI is Scaling Patient-Reported Outcomes into Structured, Submission-Ready Evidence

Scaling Patient-Reported Outcomes In the world of clinical research and drug development, patients’ own voices matter more than ever. Patient-reported outcomes (PROs) capture how people actually feel, their symptoms, quality of life, side effects, and daily functioning. Yet turning these often messy, free-text or survey responses into clean, structured data that regulators can trust has…

Read More

Ready Evidence Dossiers

How AI Helps HEOR Teams Build HTA-Ready Evidence Dossiers

HTA-Ready Evidence Dossiers HTA (Health Technology Assessment)-ready evidence dossiers represent a critical deliverable for HEOR teams seeking market access and reimbursement for new therapies. These documents compile clinical, economic, and real-world evidence to meet strict requirements from health technology assessment bodies such as NICE, CADTH, or HAS. HTA-ready evidence dossiers demand more data, tighter timelines,…

Read More

AI in Evidence Generation

ISPOR 2026: Beyond the Battle of the Bots, the Future of AI in Evidence Generation

AI in Evidence Generation was the quiet headline at ISPOR 2026 in Philadelphia this May. Most exhibit-hall chatter, though, was still about which chatbot gives the "smartest" answer. MadeAi presented four posters at ISPOR 2026. They covered literature review methodology, GenAI validation, drug repurposing, and social media listening for CSL Behring. Together, they tell a…

Read More